MOPP chemotherapy regimen
E1313881
UNEXPLORED
The MOPP chemotherapy regimen is an early combination cancer treatment protocol, historically used for Hodgkin lymphoma, that includes multiple cytotoxic drugs administered in cycles.
All labels observed (1)
| Label | Occurrences |
|---|---|
| MOPP chemotherapy regimen canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T18213151 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: MOPP chemotherapy regimen Context triple: [vincristine, usedInRegimen, MOPP chemotherapy regimen]
-
A.
VAC chemotherapy regimen
The VAC chemotherapy regimen is a combination cancer treatment protocol that typically includes vincristine, actinomycin D (dactinomycin), and cyclophosphamide, commonly used for pediatric solid tumors such as rhabdomyosarcoma.
-
B.
BEACOPP regimen
The BEACOPP regimen is an intensive multi-drug chemotherapy protocol used primarily for advanced-stage Hodgkin lymphoma.
-
C.
R-CHOP
R-CHOP is a standard chemotherapy regimen combining rituximab with multiple cytotoxic drugs, commonly used to treat non-Hodgkin lymphoma.
-
D.
ABVD regimen
The ABVD regimen is a standard chemotherapy combination used as first-line treatment for classical Hodgkin lymphoma.
-
E.
FOLFIRI regimen
The FOLFIRI regimen is a combination chemotherapy protocol, typically including folinic acid, fluorouracil, and irinotecan, commonly used to treat advanced colorectal cancer.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: MOPP chemotherapy regimen Target entity description: The MOPP chemotherapy regimen is an early combination cancer treatment protocol, historically used for Hodgkin lymphoma, that includes multiple cytotoxic drugs administered in cycles.
-
A.
VAC chemotherapy regimen
The VAC chemotherapy regimen is a combination cancer treatment protocol that typically includes vincristine, actinomycin D (dactinomycin), and cyclophosphamide, commonly used for pediatric solid tumors such as rhabdomyosarcoma.
-
B.
BEACOPP regimen
The BEACOPP regimen is an intensive multi-drug chemotherapy protocol used primarily for advanced-stage Hodgkin lymphoma.
-
C.
R-CHOP
R-CHOP is a standard chemotherapy regimen combining rituximab with multiple cytotoxic drugs, commonly used to treat non-Hodgkin lymphoma.
-
D.
ABVD regimen
The ABVD regimen is a standard chemotherapy combination used as first-line treatment for classical Hodgkin lymphoma.
-
E.
FOLFIRI regimen
The FOLFIRI regimen is a combination chemotherapy protocol, typically including folinic acid, fluorouracil, and irinotecan, commonly used to treat advanced colorectal cancer.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.